Skip to main content
Equibles
AVLN logo

AVLN · Avalyn Pharma Inc. · Executive Compensation

Track AVLN — free

Use AVLN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AVLN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$28.13 +0.71 (+2.59%) At close · Oct 2
Russell 2000 member Rebalance outlook locked
Market Cap
$1.21B
Shares
44.33M
Volume · Oct 2 526.21K Avg daily vol (3M) 242.81K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Robert Meyer, M.D. Appointed 2026-09-16
Key facts CIK 1540171 CUSIP 05348Y105 13F (30d) 1 filings 1 filers Visit website Investor relations